347 related articles for article (PubMed ID: 27388736)
1. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
Marmor MF
Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
[No Abstract] [Full Text] [Related]
2. Hydroxychloroquine Screening Alert: Change is in the Wind.
Marmor MF
Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):96-98. PubMed ID: 28195610
[TBL] [Abstract][Full Text] [Related]
3. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
4. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
Aduriz-Lorenzo PM; Aduriz-Llaneza P; Araiz-Iribarren J; Khamashta MA
Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
[TBL] [Abstract][Full Text] [Related]
5. Night Blindness, Ring Scotoma, and a Nonrecordable Electroretinogram in an Elderly Woman.
Grassi MA; Maker MP; Marmor MF
JAMA Ophthalmol; 2019 Jan; 137(1):109-110. PubMed ID: 30452517
[No Abstract] [Full Text] [Related]
6. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
Melles RB; Marmor MF
JAMA Ophthalmol; 2014 Dec; 132(12):1453-60. PubMed ID: 25275721
[TBL] [Abstract][Full Text] [Related]
7. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
[TBL] [Abstract][Full Text] [Related]
8. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
Vanderzee G; Tassi D
Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
[TBL] [Abstract][Full Text] [Related]
9. Ocular toxicity of hydroxychloroquine.
Tehrani R; Ostrowski RA; Hariman R; Jay WM
Semin Ophthalmol; 2008; 23(3):201-9. PubMed ID: 18432546
[TBL] [Abstract][Full Text] [Related]
10. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine retinopathy: A review of imaging.
Pandya HK; Robinson M; Mandal N; Shah VA
Indian J Ophthalmol; 2015 Jul; 63(7):570-4. PubMed ID: 26458473
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
13. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
[TBL] [Abstract][Full Text] [Related]
14. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
[TBL] [Abstract][Full Text] [Related]
15. AIMING FOR THE BULL'S EYE: The Cost-Utility of Screening for Hydroxychloroquine Retinopathy.
McClellan AJ; Chang JS; Smiddy WE
Retina; 2016 Oct; 36(10):1958-63. PubMed ID: 27465574
[TBL] [Abstract][Full Text] [Related]
16. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine retinopathy.
Maturi RK; Folk JC; Nichols B; Oetting TT; Kardon RH
Arch Ophthalmol; 1999 Sep; 117(9):1262-3. PubMed ID: 10496407
[No Abstract] [Full Text] [Related]
18. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
19. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
Chew AL; Sampson DM; Chelva E; Khan JC; Chen FK
Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
[TBL] [Abstract][Full Text] [Related]
20. Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.
Marmor MF; Chien FY; Johnson MW
JAMA Ophthalmol; 2013 Apr; 131(4):476-80. PubMed ID: 23710501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
